240 related articles for article (PubMed ID: 27221971)
1. Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan.
Chang CH; Sakaguchi M; Dolin P
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1196-1203. PubMed ID: 27221971
[TBL] [Abstract][Full Text] [Related]
2. Lactic acidosis incidence with metformin in patients with type 2 diabetes and chronic kidney disease: A retrospective nested case-control study.
Alvarez CA; Halm EA; Pugh MJV; McGuire DK; Hennessy S; Miller RT; Lingvay I; Vouri SM; Zullo AR; Yang H; Chansard M; Mortensen EM
Endocrinol Diabetes Metab; 2021 Jan; 4(1):e00170. PubMed ID: 33532612
[TBL] [Abstract][Full Text] [Related]
3. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.
Eppenga WL; Lalmohamed A; Geerts AF; Derijks HJ; Wensing M; Egberts A; De Smet PA; de Vries F
Diabetes Care; 2014 Aug; 37(8):2218-24. PubMed ID: 24842984
[TBL] [Abstract][Full Text] [Related]
4. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas.
Chu PY; Hackstadt AJ; Chipman J; Griffin MR; Hung AM; Greevy RA; Grijalva CG; Elasy T; Roumie CL
Diabetes Care; 2020 Jul; 43(7):1462-1470. PubMed ID: 32327421
[TBL] [Abstract][Full Text] [Related]
5. Impact of Japanese regulatory action on metformin-associated lactic acidosis in type II diabetes patients.
Hanatani T; Sai K; Tohkin M; Segawa K; Saito Y
Int J Clin Pharm; 2015 Jun; 37(3):537-45. PubMed ID: 25822043
[TBL] [Abstract][Full Text] [Related]
6. Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study.
Richy FF; Sabidó-Espin M; Guedes S; Corvino FA; Gottwald-Hostalek U
Diabetes Care; 2014 Aug; 37(8):2291-5. PubMed ID: 24879835
[TBL] [Abstract][Full Text] [Related]
7. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.
Bodmer M; Meier C; Krähenbühl S; Jick SS; Meier CR
Diabetes Care; 2008 Nov; 31(11):2086-91. PubMed ID: 18782901
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
[TBL] [Abstract][Full Text] [Related]
9. Risk of lactic acidosis in type 2 diabetes patients using metformin: A case control study.
Aharaz A; Pottegård A; Henriksen DP; Hallas J; Beck-Nielsen H; Lassen AT
PLoS One; 2018; 13(5):e0196122. PubMed ID: 29738540
[TBL] [Abstract][Full Text] [Related]
10. Relationship between metformin use and lactic acidosis in advanced chronic kidney disease: The REMIND-TMU study.
Chen CC; Ko Y; Chen CH; Hung YJ; Wei TE; Chang TH; Ke SS; Kuo KN; Chen C
Am J Med Sci; 2022 Nov; 364(5):575-582. PubMed ID: 35483434
[TBL] [Abstract][Full Text] [Related]
11. Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.
Lazarus B; Wu A; Shin JI; Sang Y; Alexander GC; Secora A; Inker LA; Coresh J; Chang AR; Grams ME
JAMA Intern Med; 2018 Jul; 178(7):903-910. PubMed ID: 29868840
[TBL] [Abstract][Full Text] [Related]
12. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease.
Kwon S; Kim YC; Park JY; Lee J; An JN; Kim CT; Oh S; Park S; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
Diabetes Care; 2020 May; 43(5):948-955. PubMed ID: 32132005
[TBL] [Abstract][Full Text] [Related]
13. Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databases.
Pedrós C; Ávila M; Gómez-Lumbreras A; Manríquez M; Morros R;
BMC Nephrol; 2019 May; 20(1):193. PubMed ID: 31146690
[TBL] [Abstract][Full Text] [Related]
14. Limitations of metformin use in patients with kidney disease: are they warranted?
Vasisht KP; Chen SC; Peng Y; Bakris GL
Diabetes Obes Metab; 2010 Dec; 12(12):1079-83. PubMed ID: 20977579
[TBL] [Abstract][Full Text] [Related]
15. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
Hung SC; Chang YK; Liu JS; Kuo KL; Chen YH; Hsu CC; Tarng DC
Lancet Diabetes Endocrinol; 2015 Aug; 3(8):605-14. PubMed ID: 26094107
[TBL] [Abstract][Full Text] [Related]
16. Metformin use and risk of lactic acidosis in people with diabetes with and without renal impairment: a cohort study in Denmark and the UK.
Li L; Jick S; Gopalakrishnan C; Heide-Jørgensen U; Nørrelund H; Sørensen HT; Christiansen CF; Ehrenstein V
Diabet Med; 2017 Apr; 34(4):485-489. PubMed ID: 27504911
[TBL] [Abstract][Full Text] [Related]
17. Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study.
Kamber N; Davis WA; Bruce DG; Davis TM
Med J Aust; 2008 Apr; 188(8):446-9. PubMed ID: 18429709
[TBL] [Abstract][Full Text] [Related]
18. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2006 Jan; (1):CD002967. PubMed ID: 16437448
[TBL] [Abstract][Full Text] [Related]
19. Metformin in patients with type 2 diabetes and kidney disease: a systematic review.
Inzucchi SE; Lipska KJ; Mayo H; Bailey CJ; McGuire DK
JAMA; 2014 Dec 24-31; 312(24):2668-75. PubMed ID: 25536258
[TBL] [Abstract][Full Text] [Related]
20. Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients.
Bipi PK; George J; Gomathy S; Gracious N; Kumar S; Mohandas MK
Saudi J Kidney Dis Transpl; 2017; 28(6):1356-1361. PubMed ID: 29265047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
